BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34546352)

  • 21. Protective effects of neurotrophic factors on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of murine adrenal chromaffin cell line tsAM5D.
    Murata T; Tsuboi M; Hikita K; Kaneda N
    J Biol Chem; 2006 Aug; 281(32):22503-16. PubMed ID: 16772303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation.
    Moriwaki K; Shinzaki S; Miyoshi E
    J Biol Chem; 2011 Dec; 286(50):43123-33. PubMed ID: 22027835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
    Kang J; Bu J; Hao Y; Chen F
    Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Recombinant Circularly Permuted Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) (Recombinant Mutant Human TRAIL) in Combination with 5-Fluorouracil in Human Colorectal Cancer Cell Lines HCT116 and SW480.
    Sun T; Zhu T; Liang X; Yang S; Zhao R
    Med Sci Monit; 2018 Apr; 24():2550-2561. PubMed ID: 29695684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus-mediated gene transfer of caspase-8 sensitizes human adenocarcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand.
    Yasui H; Adachi M; Hamada H; Imai K
    Int J Oncol; 2005 Feb; 26(2):537-44. PubMed ID: 15645141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
    Sung B; Ravindran J; Prasad S; Pandey MK; Aggarwal BB
    J Biol Chem; 2010 Nov; 285(46):35418-27. PubMed ID: 20837473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRAIL-induced apoptosis in U-1242 MG glioma cells.
    Saqr HE; Omran OM; Oblinger JL; Yates AJ
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):152-61. PubMed ID: 16462206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells.
    Petak I; Vernes R; Szucs KS; Anozie M; Izeradjene K; Douglas L; Tillman DM; Phillips DC; Houghton JA
    Cell Death Differ; 2003 Jun; 10(6):729-39. PubMed ID: 12761581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells.
    He Q; Huang Y; Sheikh MS
    Oncogene; 2004 Apr; 23(14):2554-8. PubMed ID: 14691451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
    Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
    J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
    Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
    Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.
    Longley DB; Wilson TR; McEwan M; Allen WL; McDermott U; Galligan L; Johnston PG
    Oncogene; 2006 Feb; 25(6):838-48. PubMed ID: 16247474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Death receptor 5 is activated by fucosylation in colon cancer cells.
    Zhang B; van Roosmalen IAM; Reis CR; Setroikromo R; Quax WJ
    FEBS J; 2019 Feb; 286(3):555-571. PubMed ID: 30589515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
    Park KJ; Lee SH; Kim TI; Lee HW; Lee CH; Kim EH; Jang JY; Choi KS; Kwon MH; Kim YS
    Cancer Res; 2007 Aug; 67(15):7327-34. PubMed ID: 17671202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.
    Lee YS; Lee DH; Jeong SY; Park SH; Oh SC; Park YS; Yu J; Choudry HA; Bartlett DL; Lee YJ
    J Cell Biochem; 2019 Jan; 120(1):928-939. PubMed ID: 30160785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors.
    Sung B; Prasad S; Ravindran J; Yadav VR; Aggarwal BB
    Free Radic Biol Med; 2012 Nov; 53(10):1977-87. PubMed ID: 22922338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
    Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
    Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.